Abstract:Acute kidney injury (AKI) is common in hospital patients. Delayed diagnosis and treatment of AKI due to the lack of efficient early diagnosis is an important cause of its high mortality. While fluorescence imaging seems promising to non-intrusively interrogate AKI-related biomarkers, the low kidney contrast of many fluorophores conferred by their relatively low abundance of distribution in the kidney limits their application for AKI detection. Herein, we discovered a near-infrared fluorophore with inherent kidney-targeting ability. Based on this fluorophore, a fluorogenic probe (KNP-1) was developed by targeting peroxynitrite (ONOO−), which is upregulated at the early onset of AKI. KNP-1 exhibits desirable kidney distribution after intravenous administration and is fluorescent only after activation by ONOO−. These properties lead to excellent kidney contrast imaging results. KNP-1 is capable of detecting both nephrotoxin-induced and ischemia-reperfusion injury-induced AKI in live mice. Temporally resolved imaging of AKI-disease model mice with KNP-1 suggests a gradual increase in renal ONOO− levels with disease progression. Notably, the upregulation of ONOO− can be observed at least 24 h earlier than the clinically popular sCr and BUN methods. Blocking ONOO− generation also proves beneficial. These results highlight the applicability of this inherently tissue targeting-based strategy for designing probes with desirable imaging contrast; potentiate ONOO− as a biomarker and target for AKI early diagnosis and medical intervention; and imply the clinical relevance of KNP-1 for AKI early detection.

Detection of Kidney Dysfunction through In Vivo Magnetic Resonance Imaging with Renal-Clearable Gadolinium Nanoprobes

Noninvasive Diagnosis of Kidney Dysfunction Using a Small-Molecule Manganese-Based Magnetic Resonance Imaging Probe

A Biodegradable Bismuth–gadolinium-Based Nano Contrast Agent for Accurate Identification and Imaging of Renal Insufficiency in Vivo

Highly Sensitive Early Diagnosis of Kidney Damage Using Renal Clearable Zwitterion‐Coated Ferrite Nanoprobe via Magnetic Resonance Imaging In Vivo

Noninvasive Staging of Kidney Dysfunction Enabled by Renal-Clearable Luminescent Gold Nanoparticles

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Non-invasive detection of the early phase of kidney injury by photoacoustic/computed tomography imaging.

Walking Dead Macrophage-Based Positive Enhancement MRI for Ultrahighly Efficient Diagnosis of Nephritis

Single-point Mutated Lanmodulin As a High-Performance MRI Contrast Agent for Vascular and Kidney Imaging

Intrarenal pH‐Responsive Self‐Assembly of Luminescent Gold Nanoparticles for Diagnosis of Early Kidney Injury

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Fluorinated 1,7-DO2A-Based Iron(II) Complexes as Sensitive 19F MRI Molecular Probes for Visualizing Renal Dysfunction in Living Mice

Bioinspired BSA@polydopamine@Fe Nanoprobe with Self-Purification Capacity for Targeted Magnetic Resonance Imaging of Acute Kidney Injury

A Contrast Examination of Proinflammatory Effects on Kidney Function for γ-Fe2O3 NP and Gadolinium Dimeglumine

Nagdf4 Nanoparticle-Based Molecular Probes for Magnetic Resonance Imaging of Intraperitoneal Tumor Xenografts in Vivo

Renal clearing carbon dots-based near-infrared fluorescent super-small nanoprobe for renal imaging

Molecular optical imaging probes for early diagnosis of drug-induced acute kidney injury

An inherently kidney-targeting near-infrared fluorophore based probe for early detection of acute kidney injury

High-Performance Upconversion Nanoprobes for Multimodal Mr Imaging of Acute Ischemic Stroke

Renal-clearable Nanoprobes for Optical Imaging and Early Diagnosis of Diseases

Ultracompact Iron Oxide Nanoparticles with a Monolayer Coating of Succinylated Heparin: A New Class of Renal-Clearable and Nontoxic T1 Agents for High-Field MRI.